GRAIL, LLC

NASDAQ:GRAL USA Diagnostics & Research
Market Cap
$1.91 Billion
Market Cap Rank
#5676 Global
#3315 in USA
Share Price
$47.37
Change (1 day)
+3.54%
52-Week Range
$21.39 - $116.06
All Time High
$116.06
About

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The compan… Read more

GRAIL, LLC (GRAL) - Total Assets

Latest total assets as of December 2025: $2.92 Billion USD

Based on the latest financial reports, GRAIL, LLC (GRAL) holds total assets worth $2.92 Billion USD as of December 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

GRAIL, LLC - Total Assets Trend (2018–2025)

This chart illustrates how GRAIL, LLC’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

GRAIL, LLC - Asset Composition Analysis

Current Asset Composition (December 2025)

GRAIL, LLC's total assets of $2.92 Billion consist of 32.6% current assets and 67.4% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 8.6%
Accounts Receivable $18.30 Million 0.6%
Inventory $16.02 Million 0.6%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $1.85 Billion 63.3%
Goodwill $0.00 0.0%

Asset Composition Trend (2018–2025)

This chart illustrates how GRAIL, LLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: GRAIL, LLC's current assets represent 32.6% of total assets in 2025, a decrease from 94.5% in 2018.
  • Cash Position: Cash and equivalents constituted 8.6% of total assets in 2025, down from 13.9% in 2018.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 63.0% of total assets, an increase from 0.0% in 2018.
  • Asset Diversification: The largest asset category is intangible assets at 63.3% of total assets.

GRAIL, LLC Competitors by Total Assets

Key competitors of GRAIL, LLC based on total assets are shown below.

Company Country Total Assets
ADCNF
OTCGREY:ADCNF
USA $4.51 Billion
Berry Genomics Co Ltd
SHE:000710
China CN¥2.34 Billion
Malaysian Genomics Resource
KLSE:0155
Malaysia RM20.70 Million
NSN Co. Ltd
KQ:031860
Korea ₩60.96 Billion
JOONGANG DNM Co.Ltd
KQ:051980
Korea ₩121.79 Billion
GeneMatrix Inc
KQ:109820
Korea ₩28.03 Billion
Genoray Co. Ltd
KQ:122310
Korea ₩125.67 Billion
Green Cross Lab Cell Corporation
KQ:144510
Korea ₩565.79 Billion

GRAIL, LLC - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.00 - 0.05

Lower asset utilization - GRAIL, LLC generates 0.05x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -96.38% - -12.81%

Negative ROA - GRAIL, LLC is currently not profitable relative to its asset base.

GRAIL, LLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 11.97 10.66 10.53
Quick Ratio 11.97 10.42 10.53
Cash Ratio 0.00 0.00 0.00
Working Capital $874.18 Million $ 742.94 Million $ 578.37 Million

GRAIL, LLC - Advanced Valuation Insights

This section examines the relationship between GRAIL, LLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.72
Latest Market Cap to Assets Ratio 0.54
Asset Growth Rate (YoY) -2.1%
Total Assets $2.92 Billion
Market Capitalization $1.57 Billion USD

Valuation Analysis

Below Book Valuation: The market values GRAIL, LLC's assets below their book value (0.54 x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: GRAIL, LLC's assets decreased by 2.1% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for GRAIL, LLC (2018–2025)

The table below shows the annual total assets of GRAIL, LLC from 2018 to 2025.

Year Total Assets Change
2025-12-31 $2.92 Billion -2.05%
2024-12-31 $2.98 Billion -34.53%
2023-12-31 $4.56 Billion -18.66%
2022-12-31 $5.60 Billion -42.47%
2021-12-31 $9.74 Billion +1278.73%
2020-12-31 $706.30 Million +11.14%
2019-12-31 $635.52 Million -7.47%
2018-12-31 $686.85 Million --